Compounding Pharmacies Market

FMI is of the opinion that supplier preference will be decided by formulation flexibility, prescription responsiveness, and quality-led dispensing reliability, as healthcare providers place greater emphasis on personalized therapy access, patient-specific dosing, and continuity across customized treatment pathways.